Rise Advisors’s EyePoint Inc EYPT Stock Holding History

Rise Advisors’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48	Closed	-$684	–	559
2025 Q3	$684	Buy	+48	New	+$553	﹤0.01%	1335

Other funds holding EYPT

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Rise Advisors's EYPT Position: Q4 2025 in Review

Rise Advisors sold out of EyePoint Inc (EYPT) in Q4 2025, closing a stake of 48 shares — an estimated $684 sold.

Rise Advisors first reported a position in EYPT in Q3 2025 and held it in 1 quarter. The position peaked at $684 in Q3 2025. 166 funds tracked by Wall St. Rank hold EYPT as of Q4 2025.

Rise Advisors reported no remaining EyePoint Inc position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 48 EyePoint Inc shares in Q4 2025, an estimated $684.
Rise Advisors first reported a position in EyePoint Inc in Q3 2025 and held it in 1 quarter.
Rise Advisors's EyePoint Inc position peaked at $684 in Q3 2025.
166 funds tracked by Wall St. Rank held EyePoint Inc as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.